Advertisement

Valneva Extends Trials On COVID Vaccine Candidate

"Valneva continues discussions with the European Commission regarding a potential VLA2001 supply contract. The company is also actively pursuing opportunities to make VLA2001 available to other customers, subject to positive Cov-Compare data and regulatory approval," it said in a statement.

French vaccines company Valneva said on Thursday that it was expanding trials on its 'VLA2001' COVID-19 vaccine candidate and remained in talks with the European Commission over a potential contract.

"Valneva continues discussions with the European Commission regarding a potential VLA2001 supply contract. The company is also actively pursuing opportunities to make VLA2001 available to other customers, subject to positive Cov-Compare data and regulatory approval," it said in a statement.

(Reuters)


Tags assigned to this article:
Valneva Covid vaccine trials european commission

Advertisement

Around The World